MedEx answers any queries you might have regarding Osimertinib-80 purchase, shipping and payment terms.
Feel free to contact support through inquiry form, MedeEx is fully dedicated towards your needs 24/7.
Osimertinib 80 mg is an innovative drug, whose effect is aimed at preventing the replication of cancer cells. It is used for the treatment of patients suffering, diagnosed with non-small cell lung cancer.
What were the results of clinical trials?
During the clinical trials, the scientists have found that the drug significantly reduced the risk of developing neoplasms. Compared to the other methods of drug treatment, the correct use of Osimertinib 80 mg reduces the mortality rate by approximately 53%, which is excellent considering that lung cancer is very hard to heal. Osimertinib 80 mg is intended for the patients, who have almost no chance for recovery. It is important to take into account the fact that the treatment must be conducted under the supervision of oncologist (who also defines the drug dosage). Before starting the treatment, the patients have to pass a special test to confirm the presence of T790M mutation, which is an indication for use.
Way of use and dosage:
Orally, irrespective of the mealtime (80 mg once a day).
Highest daily dose: 80 mg.
Highest single dose: 80 mg.
Form of production and contraindications.
The drug is sold in the form of pills with a different dosage (you can buy 80 mg). The treatment shall be continued until the patients has acceptable side effects (while maintain the positive results). If the unpleasant feelings increase and the disease progresses, the treatment should be cancelled.
Depending on the severity of the symptoms, the doctor must adjust the dose or discontinue treatment. To identify any complications timely, patients are also encouraged to regularly undergo ultrasound cardiography and radionuclide angiography. Osimertinib 80 mg may affect the development of the fetus; so patients should not plan pregnancy during therapy. Female patients are recommended to use appropriate methods of contraception during treatment and within six weeks after completion of the drug; patients to men – during treatment and within four months after completion of the drug. It is necessary to inform the attending physician of any other medications taken by the patient, including vitamins, food additives and herbal remedies.